Medicare AdvantageCoverageHigh impact
MA11.002p, Hematopoietic Stem Cell Transplantation
Independence Blue Cross·Oncology, Hematology·Medical Policy
Effective date
Oct 20, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage updated medical necessity criteria for hematopoietic stem cell transplantation procedures. This affects coverage determinations and prior authorization requirements for bone marrow and stem cell transplant procedures.
Action Required
By October 20, 2025: Billing team must review updated medical necessity criteria for all hematopoietic stem cell transplantation claims. Update prior authorization processes to align with new Medicare Advantage requirements. Contact Medicare Advantage plans to confirm specific documentation requirements for stem cell transplant procedures to avoid claim denials.